The combination of gemcitabine and ginsenoside Rh2 enhances the immune function of dendritic cells against pancreatic cancer via the CARD9-BCL10-MALT1 / NF-κB pathway DOI
Qing Li, Jialuo He, Senlin Li

и другие.

Clinical Immunology, Год журнала: 2022, Номер 248, С. 109217 - 109217

Опубликована: Дек. 27, 2022

Язык: Английский

The role of PI3k/AKT signaling pathway in attenuating liver fibrosis: a comprehensive review DOI Creative Commons
Emad Shamsan,

Maged Almezgagi,

Mohammed Gamah

и другие.

Frontiers in Medicine, Год журнала: 2024, Номер 11

Опубликована: Март 25, 2024

Excessive accumulation of extracellular matrix (ECM) components within the liver leads to a pathological condition known as fibrosis. Alcohol abuse, non-alcoholic fatty disease (NAFLD), autoimmune issues, and viral hepatitis cause chronic injury. Exploring potential therapeutic targets understanding molecular mechanisms involved in fibrosis are essential for development effective interventions. The goal this comprehensive review is explain how PI3K/AKT signaling pathway contributes reduction target investigated through summary results from vivo vitro studies. Studies focusing on activation have shown significant decrease markers improvement function. emphasizes may prevent ECM synthesis hepatic stellate cell (HSC) activation, ultimately reducing fibrotic response. specific downstream effectors constitute rapidly developing field study. In conclusion, plays role attenuating Its complex regulating HSC production, demonstrated both , underscores its approach managing slowing progression. A provides valuable insights into future developments implications clinical applications.

Язык: Английский

Процитировано

23

The decrease of selenoprotein K induced by selenium deficiency in diet improves apoptosis and cell progression block in chicken liver via the PTEN/PI3K/AKT pathway DOI
Wenyue Zhang,

Kai Yin,

Jiahui Shi

и другие.

Free Radical Biology and Medicine, Год журнала: 2022, Номер 189, С. 20 - 31

Опубликована: Июль 13, 2022

Язык: Английский

Процитировано

43

Kinsenoside alleviates inflammation and fibrosis in experimental NASH mice by suppressing the NF-κB/NLRP3 signaling pathway DOI

Yanfang Deng,

Qianqian Xu, Tianqi Chen

и другие.

Phytomedicine, Год журнала: 2022, Номер 104, С. 154241 - 154241

Опубликована: Июнь 15, 2022

Язык: Английский

Процитировано

39

SIRT1: Harnessing multiple pathways to hinder NAFLD DOI Creative Commons
Cheng Tian, Rongrong Huang, Ming Xiang

и другие.

Pharmacological Research, Год журнала: 2024, Номер 203, С. 107155 - 107155

Опубликована: Март 23, 2024

Non-alcoholic fatty liver disease (NAFLD) encompasses hepatic steatosis, non-alcoholic steatohepatitis (NASH), fibrosis, cirrhosis, and hepatocellular carcinoma. It is the primary cause of chronic disorders, with a high prevalence but no approved treatment. Therefore, it indispensable to find trustworthy therapy for NAFLD. Recently, mounting evidence illustrates that Sirtuin 1 (SIRT1) strongly associated SIRT1 activation or overexpression attenuate NAFLD, while deficiency aggravates Besides, an array therapeutic agents, including natural compounds, synthetic traditional Chinese medicine formula, stem cell transplantation, alleviates NALFD via upregulation. Mechanically, NAFLD by reestablishing autophagy, enhancing mitochondrial function, suppressing oxidative stress, coordinating lipid metabolism, as well reducing hepatocyte apoptosis inflammation. In this review, we introduced structure function briefly, summarized effect on its mechanism, along application agonists in treating

Язык: Английский

Процитировано

14

Immune Checkpoints and the Immunology of Liver Fibrosis DOI Creative Commons
Ioannis Tsomidis, Argyro Voumvouraki, Elias Kouroumalis

и другие.

Livers, Год журнала: 2025, Номер 5(1), С. 5 - 5

Опубликована: Янв. 27, 2025

Liver fibrosis is a very complicated dynamic process where several immune cells are involved. Both innate and adaptive immunity implicated, their interplay always present. Multi-directional interactions between liver macrophages, hepatic stellate (HSCs), cells, cytokines important for the induction perpetuation of fibrosis. Detailed studies proteomics transcriptomics have produced new evidence role individual in cirrhosis. Most these controlled by various checkpoints whose main function to maintain homeostasis implicated cells. Recent indicates that involved In particular, programmed cell death protein 1 (PD-1), death-ligand (PD-L1), cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) been investigated, particularly after availability checkpoint inhibitors. Their activation leads exhaustion CD4+ve CD8+ve promotion this review, current pathogenesis immunological abnormalities discussed. The recent data on involvement identified as possible targets future interventions.

Язык: Английский

Процитировано

1

Kinsenoside mitigates myocardial ischemia/reperfusion-induced ferroptosis via activation of the Akt/Nrf2/HO-1 pathway DOI
Rong Wang, Siwei Dong, Rui Xia

и другие.

European Journal of Pharmacology, Год журнала: 2023, Номер 956, С. 175985 - 175985

Опубликована: Авг. 10, 2023

Язык: Английский

Процитировано

22

PD-1/PD-L1 axis in organ fibrosis DOI Creative Commons
Youliang Zhao,

Yaqian Qu,

Changfu Hao

и другие.

Frontiers in Immunology, Год журнала: 2023, Номер 14

Опубликована: Май 19, 2023

Fibrosis is a pathological tissue repair activity in which many myofibroblasts are activated and extracellular matrix excessively accumulated, leading to the formation of permanent scars finally organ failure. A variety organs, including lung, liver, kidney, heart, skin, can undergo fibrosis under stimulation various exogenous or endogenous pathogenic factors. At present, pathogenesis still not fully elucidated, but it known that immune system plays key role initiation progression fibrosis. Immune checkpoint molecules regulators maintain tolerance homeostasis, among programmed cell death protein 1/programmed ligand 1 (PD-1/PD-L1) axis has attracted much attention. The exciting achievements tumor immunotherapy targeting PD-1/PD-L1 provide new insights into its use as therapeutic target for other diseases. In recent years, been preliminarily explored, further confirming close relationship signaling, regulation, This review discusses structure, expression, function, regulatory mechanism PD-1 PD-L1, summarizes research progress signaling fibrotic

Язык: Английский

Процитировано

21

ADORA2B, transcriptionally suppressing by MYC, promotes ferroptosis of chondrocytes via inhibition of the PI3K/Akt pathway in mice with osteoarthritis DOI
Shen Li,

Jiangbo Han,

Jiongzhe Cao

и другие.

Environmental Toxicology, Год журнала: 2024, Номер 39(5), С. 2487 - 2501

Опубликована: Янв. 4, 2024

Abstract Recent studies have shown that chondrocyte ferroptosis contributes importantly to the pathogenesis of osteoarthritis (OA). However, it is largely unknown how regulated. In this study, data sets GSE167852 and GSE190184 were downloaded from Gene Expression Omnibus (GEO) database, 161 differentially expressed genes (DEGs) related screened by bioinformatics analysis. Subsequently, ADORA2B was as a candidate gene DEGs, which significantly upregulated in palmitic acid (PA) treated chondrocytes. CCK‐8, EdU, Western blotting, ferroptosis‐related kits assays demonstrated knockdown constrained promoted viability Overexpression ferroptosis, while PI3K/Akt pathway inhibitor LY294002 reversed promotion on ferroptosis. Dual‐luciferase reporter assay chromatin immunoprecipitation (ChIP) indicated MYC transcription suppressor ADORA2B, overexpression viability, inhibited chondrocytes, abated inhibition vivo experiments showed alleviated cartilage tissue damage OA mice, able overexpression. summary, transcriptionally suppressing MYC, promotes chondrocytes via pathway. Thus, can be used potential treatment target for diseases.

Язык: Английский

Процитировано

7

Role of glycolysis in inflammatory bowel disease and its associated colorectal cancer DOI Creative Commons
Yuxuan Xia, Zhang Li, Dickson Kofi Wiredu Ocansey

и другие.

Frontiers in Endocrinology, Год журнала: 2023, Номер 14

Опубликована: Окт. 10, 2023

Inflammatory bowel disease (IBD) has been referred to as the “green cancer,” and its progression colorectal cancer (CRC) poses a significant challenge for medical community. A common factor in their development is glycolysis, crucial metabolic mechanism of living organisms, which also involved other diseases. In IBD, glycolysis affects gastrointestinal components such intestinal microbiota, mucosal barrier function, immune system, including macrophages, dendritic cells, T neutrophils, while CRC, it linked various pathways, phosphatidylinositol-3-kinase (PI3K)/AKT, AMP-activated protein kinase (AMPK), mammalian target rapamycin (mTOR), transcription factors p53, Hypoxia-inducible (HIF), c-Myc. Thus, comprehensive study essential better understanding pathogenesis therapeutic targets both IBD CRC. This paper reviews role diseases, particularly via effects on immunity, integrity, signaling some strategies targeting glycolytic enzymes.

Язык: Английский

Процитировано

16

Jaceosidin attenuates the progression of hepatic fibrosis by inhibiting the VGLL3/HMGB1/TLR4 signaling pathway DOI
Youli Yao,

Xiaoling Zuo,

Feng Shao

и другие.

Phytomedicine, Год журнала: 2024, Номер 128, С. 155502 - 155502

Опубликована: Март 11, 2024

Язык: Английский

Процитировано

6